Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
A Quick reCAP: Discovering Cryptococcus neoformans Capsule Mutants
Daphne Boodwa-Ko,
Tamara L. Doering
Department of Molecular Microbiology
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
DBBS - Biochemistry, Biophysics, and Structural Biology
DBBS - Molecular Cell Biology
DBBS - Molecular Microbiology and Microbial Pathogenesis
DBBS - Plant and Microbial Biosciences
Institute for Public Health
Institute of Clinical and Translational Sciences (ICTS)
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A Quick reCAP: Discovering Cryptococcus neoformans Capsule Mutants'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cryptococcus Neoformans
100%
Capsule Biosynthesis
100%
Gene Expression Analysis
50%
AIDS/HIV
50%
Virulence
50%
Host-pathogen Interactions
50%
Gene Deletion
50%
Mutagenesis
50%
Immunocompromised Host
50%
Combined Technique
50%
Pathogenic Yeast
50%
Meningoencephalitis
50%
Leading Causes of Death
50%
Antibody Binding
50%
Opportunistic Fungal Pathogen
50%
Genetic Screening
50%
AIDS Patients
50%
Computational Modeling
50%
Novel Therapeutic Targets
50%
Polysaccharide Capsule
50%
Neoformans
50%
Morphological Examination
50%
Physical Separation
50%
Immunology and Microbiology
Cryptococcus neoformans
100%
Host-Pathogen Interaction
50%
Infectious Agent
50%
Gene Deletion
50%
HIV/AIDS
50%
Binding Antibody
50%
Morphology
50%
Mutagenesis
50%
Immunocompromised Patient
50%
Meningoencephalitis
50%
Gene Expression Assay
50%
Pharmacology, Toxicology and Pharmaceutical Science
Cryptococcus neoformans
100%
HIV
50%
Meningoencephalitis
50%
Polysaccharide
50%
Infectious Agent
50%
Mutagenesis
50%
Host Pathogen Interaction
50%
Immunocompromised Patient
50%